The association of its overexpression with GCs proliferation was demonstrated in PCOS (polycystic ovary syndrome) study, where it activated the MAPK/ERK pathway and promoted the disorder [77]. This evidence concerns the gene MAPK1 and polycystic ovary syndrome.